Great news! Wait-listing for liver transplantation among patients with decompensated cirrhosis has decreased by approximately 30% between 2003 to 2015 with the help of direct-acting antiviral (DAA) therapy. DAA was created recently during 2014-2015 and has finally taken a national level impact on patients with HCV.
Learn more here: bit.ly/2eGBioy
